As on Thursday, X4 Pharmaceuticals Inc (NASDAQ: XFOR) started slowly as it slid -4.21% to $3.64, before settling in for the price of $3.8 at the close. Taking a more long-term approach, XFOR posted a 52-week range of $1.35-$26.83.
It was noted that the giant of the Healthcare sector posted annual sales growth of 47.41% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 47.41%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 63.60%. This publicly-traded company’s shares outstanding now amounts to $87.44 million, simultaneously with a float of $78.31 million. The organization now has a market capitalization sitting at $318.27 million. At the time of writing, stock’s 50-day Moving Average stood at $3.50, while the 200-day Moving Average is $4.62.
X4 Pharmaceuticals Inc (XFOR) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. X4 Pharmaceuticals Inc’s current insider ownership accounts for 10.44%, in contrast to 32.31% institutional ownership. According to the most recent insider trade that took place on Oct 23 ’25, this organization’s Executive Chairman bought 86,206 shares at the rate of 2.90, making the entire transaction reach 249,997 in total value, affecting insider ownership by 376,087. Preceding that transaction, on May 16 ’25, Company’s Chief Commercial Officer bought 1,032 for 2.48, making the whole transaction’s value amount to 2,561. This particular insider is now the holder of 25,337 in total.
X4 Pharmaceuticals Inc (XFOR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year. X4 Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 63.60% and is forecasted to reach -0.92 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 48.40% through the next 5 years, which can be compared against the 47.41% growth it accomplished over the previous five years trading on the market.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Let’s observe the current performance indicators for X4 Pharmaceuticals Inc (XFOR). It’s Quick Ratio in the last reported quarter now stands at 5.48. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.37.
In the same vein, XFOR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -10.01, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -0.92 at the market close of one year from today.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Through scrutinizing the latest numbers posted by the [X4 Pharmaceuticals Inc, XFOR], it can be observed that its last 5-days Average volume of 0.5 million was lower the volume of 1.44 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 62.31% While, its Average True Range was 46.96.
Raw Stochastic average of X4 Pharmaceuticals Inc (XFOR) in the period of the previous 100 days is set at 65.80%, which indicates a major rise in contrast to 59.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.23 that was lower than 0.32 volatility it exhibited in the past 100-days period.
